Bayer Sells Dr. Scholl’s

Bayer has sold Dr. Scholl’s to Yellow Wood Partners for $585 million.

The iconic brand has a 110 year heritage with unmatched brand equity in the foot care category and the No. 1 sales position in the most attractive segments. The brand generated sales of $234 million in 2018 through the sale of its inserts and treatment products. 
 
With the acquisition of Dr. Scholl’s, Yellow Wood Partners will create a stand-alone company.

“The Yellow Wood team is excited to become the next steward of the iconic Dr. Scholl’s™ brand,” said Dana Schmaltz of Yellow Wood Partners. “Dr. Scholl’s is the leading brand in the footcare category and we see great potential to grow the brand in its existing and other sales channels. The brand fits extremely well into the Yellow Wood consumer-focused business model as our firm has the operating experience from other carve-out investments to work with the Bayer employees who are continuing with the brand to build an exciting new stand-alone platform company.”

Bayer took ownership of Dr. Scholl’s  in late 2014. 

Specifically, Yellow Wood Partners will acquire the product rights to Dr. Scholl’s in the Americas and take over approximately 30 dedicated brand personnel in the US and Canada, including sales and marketing, R&D and others
 
The transaction is expected to close in Q4 2019 subject to the satisfaction of customary closing conditions, including approval by the competition authorities.